Michelle Paulsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michelle Paulsen has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Christoph Plass
Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany
2 shared publications Dieter Weichenhan
Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany
2 shared publications- Joschka Hey
Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany
2 shared publications - Marcus Alexander Mall
Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany
2 shared publications Ana Farias
Affiliation Respiratory Infections Section, St Mary’s campus, National Heart and Lung Institute, Imperial College London, London, United Kingdom
1 shared publication- Artur Veloso
Repare Therapeutics, Cambridge, Massachusetts. 2
1 shared publication
Latest Publications
- 26 August 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 7 (74) , eabn8144
Transcriptional regulation of the thymus master regulatorFoxn1
FOXN1 is a transcription factor critical for the development of both thymic epithelial cell (TEC) and hair follicle cell (HFC) compartments. However, mechanisms controlling its expression remain poorly understood. To address this question, we performed thorough analyses of the evolutionary conservation and chromatin status of theFoxn1locus in different tissues and states and identified several putative cis-regulatory regions unique to TECs versus HFCs. Furthermore, experiments using genetically modified mice with specific deletions in theFoxn1locus and additional bioinformatic analyses helped us identify key regions and transcription factors involved in either positive or negative regulation ofFoxn1in both TECs and HFCs. Specifically, we identified SIX1 and FOXN1 itself as key factors inducingFoxn1expression in embryonic and neonatal TECs. Together, our data provide important mechanistic insights into the transcriptional regulation of theFoxn1gene in TEC versus HFC and highlight the role of FOXN1 in its autoregulation.
- 26 August 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 7 (74) , eabn8144
Transcriptional regulation of the thymus master regulatorFoxn1
FOXN1 is a transcription factor critical for the development of both thymic epithelial cell (TEC) and hair follicle cell (HFC) compartments. However, mechanisms controlling its expression remain poorly understood. To address this question, we performed thorough analyses of the evolutionary conservation and chromatin status of theFoxn1locus in different tissues and states and identified several putative cis-regulatory regions unique to TECs versus HFCs. Furthermore, experiments using genetically modified mice with specific deletions in theFoxn1locus and additional bioinformatic analyses helped us identify key regions and transcription factors involved in either positive or negative regulation ofFoxn1in both TECs and HFCs. Specifically, we identified SIX1 and FOXN1 itself as key factors inducingFoxn1expression in embryonic and neonatal TECs. Together, our data provide important mechanistic insights into the transcriptional regulation of theFoxn1gene in TEC versus HFC and highlight the role of FOXN1 in its autoregulation.
- Open Access
- 2 February 2022
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 18 (2) , e1010272
Type I interferons and MAVS signaling are necessary for tissue resident memory CD8+ T cell responses to RSV infection
Respiratory syncytial virus (RSV) can cause bronchiolitis and viral pneumonia in young children and the elderly. Lack of vaccines and recurrence of RSV infection indicate the difficulty in eliciting protective memory immune responses. Tissue resident memory T cells (TRM) can confer protection from pathogen re-infection and, in human experimental RSV infection, the presence of lung CD8+ TRM cells correlates with a better outcome. However, the requirements for generating and maintaining lung TRM cells during RSV infection are not fully understood. Here, we use mouse models to assess the impact of innate immune response determinants in the generation and subsequent expansion of the TRM cell pool during RSV infection. We show that CD8+ TRM cells expand independently from systemic CD8+ T cells after RSV re-infection. Re-infected MAVS and MyD88/TRIF deficient mice, lacking key components involved in innate immune recognition of RSV and induction of type I interferons (IFN-α/β), display impaired expansion of CD8+ TRM cells and reduction in antigen specific production of granzyme B and IFN-γ. IFN-α treatment of MAVS deficient mice during primary RSV infection restored TRM cell expansion upon re-challenge but failed to recover TRM cell functionality. Our data reveal how innate immunity, including the axis controlling type I IFN induction, instructs and regulates CD8+ TRM cell responses to RSV infection, suggesting possible mechanisms for therapeutic intervention.
- 2 February 2022
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 18 (2) , e1010272
Open AccessType I interferons and MAVS signaling are necessary for tissue resident memory CD8+ T cell responses to RSV infection
Respiratory syncytial virus (RSV) can cause bronchiolitis and viral pneumonia in young children and the elderly. Lack of vaccines and recurrence of RSV infection indicate the difficulty in eliciting protective memory immune responses. Tissue resident memory T cells (TRM) can confer protection from pathogen re-infection and, in human experimental RSV infection, the presence of lung CD8+ TRM cells correlates with a better outcome. However, the requirements for generating and maintaining lung TRM cells during RSV infection are not fully understood. Here, we use mouse models to assess the impact of innate immune response determinants in the generation and subsequent expansion of the TRM cell pool during RSV infection. We show that CD8+ TRM cells expand independently from systemic CD8+ T cells after RSV re-infection. Re-infected MAVS and MyD88/TRIF deficient mice, lacking key components involved in innate immune recognition of RSV and induction of type I interferons (IFN-α/β), display impaired expansion of CD8+ TRM cells and reduction in antigen specific production of granzyme B and IFN-γ. IFN-α treatment of MAVS deficient mice during primary RSV infection restored TRM cell expansion upon re-challenge but failed to recover TRM cell functionality. Our data reveal how innate immunity, including the axis controlling type I IFN induction, instructs and regulates CD8+ TRM cell responses to RSV infection, suggesting possible mechanisms for therapeutic intervention.
- Open Access
- 11 November 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-18
Epigenetic reprogramming of airway macrophages promotes polarization and inflammation in muco-obstructive lung disease
Lung diseases, such as cystic fibrosis and COPD, are characterized by mucus obstruction and chronic airway inflammation, but their mechanistic link remains poorly understood. Here, we focus on the function of the mucostatic airway microenvironment on epigenetic reprogramming of airway macrophages (AM) and resulting transcriptomic and phenotypical changes. Using a mouse model of muco-obstructive lung disease (Scnn1b-transgenic), we identify epigenetically controlled, differentially regulated pathways and transcription factors involved in inflammatory responses and macrophage polarization. Functionally, AMs from Scnn1b-transgenic mice have reduced efferocytosis and phagocytosis, and excessive inflammatory responses upon lipopolysaccharide challenge, mediated through enhanced Irf1 function and expression. Ex vivo stimulation of wild-type AMs with native mucus impairs efferocytosis and phagocytosis capacities. In addition, mucus induces gene expression changes, comparable with those observed in AMs from Scnn1b-transgenic mice. Our data show that mucostasis induces epigenetic reprogramming of AMs, leading to changes favoring tissue damage and disease progression. Targeting these altered AMs may support therapeutic approaches in patients with muco-obstructive lung diseases.
- 11 November 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-18
Open AccessEpigenetic reprogramming of airway macrophages promotes polarization and inflammation in muco-obstructive lung disease
Lung diseases, such as cystic fibrosis and COPD, are characterized by mucus obstruction and chronic airway inflammation, but their mechanistic link remains poorly understood. Here, we focus on the function of the mucostatic airway microenvironment on epigenetic reprogramming of airway macrophages (AM) and resulting transcriptomic and phenotypical changes. Using a mouse model of muco-obstructive lung disease (Scnn1b-transgenic), we identify epigenetically controlled, differentially regulated pathways and transcription factors involved in inflammatory responses and macrophage polarization. Functionally, AMs from Scnn1b-transgenic mice have reduced efferocytosis and phagocytosis, and excessive inflammatory responses upon lipopolysaccharide challenge, mediated through enhanced Irf1 function and expression. Ex vivo stimulation of wild-type AMs with native mucus impairs efferocytosis and phagocytosis capacities. In addition, mucus induces gene expression changes, comparable with those observed in AMs from Scnn1b-transgenic mice. Our data show that mucostasis induces epigenetic reprogramming of AMs, leading to changes favoring tissue damage and disease progression. Targeting these altered AMs may support therapeutic approaches in patients with muco-obstructive lung diseases.
- Open Access
- 16 December 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (12)
Correction: Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin
- 16 December 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (12)
Open AccessCorrection: Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin